Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

AMPIO PHARMACEUTICALS, INC.

(AMPE)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
01/19/2022 01/20/2022 01/21/2022 01/24/2022 01/25/2022 Date
0.5333(c) 0.495(c) 0.48(c) 0.48(c) 0.4661 Last
1 377 940 1 139 557 1 432 715 1 785 578 1 012 681 Volume
+6.98% -7.18% -3.03% 0.00% -2.90% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 - - -
Net income 2021 -14,8 M - -
Net Debt 2021 - - -
P/E ratio 2021 -6,86x
Yield 2021 -
Sales 2022 - - -
Net income 2022 -15,0 M - -
Net Debt 2022 - - -
P/E ratio 2022 -6,86x
Yield 2022 -
Capitalization 109 M 109 M -
Capi. / Sales 2021 -
Capi. / Sales 2022 -
Nbr of Employees 18
Free-Float 93,2%
More Financials
Company
Ampio Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and advancement of immunology-based therapies for prevalent inflammatory conditions. The Company's lead product candidate is Ampion, which contains a blood-derived cyclized peptide and small molecules that target multiple pathways in the innate immune response characteristic of inflammatory disease. Ampion is in development as an... 
More about the company
All news about AMPIO PHARMACEUTICALS, INC.
01/06Ampio Pharmaceuticals Presents Corporate Overview at H.C. Wainwright Bioconnect Confere..
PR
2021Ampio pharmaceuticals' ceo mike martino issues letter to stockholders
AQ
2021AMPIO PHARMACEUTICALS : ​Ampio Pharmaceuticals' CEO Mike Martino Issues Letter to St..
PU
2021AMPIO PHARMACEUTICALS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits ..
AQ
2021AMPIO PHARMACEUTICALS : ​AMPIO PHARMACEUTICALS ANNOUNCES PRICING OF $22.5 MILLION RE..
PU
2021AMPIO PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Other Events, Fi..
AQ
2021AMPIO PHARMACEUTICALS : to Host Business Update Call with Chairman and CEO Mike Martino on..
PU
2021AMPIO PHARMACEUTICALS : ​Board Member Michael Martino to Become Interim Chairman and..
PU
2021AMPIO PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Financial Stateme..
AQ
2021AMPIO PHARMACEUTICALS : Announces Shareholder / Business Update Call with its CEO & Chairm..
PU
2021Ampio Pharmaceuticals - BOARD MEMBER MICHAEL MARTINO TO BECOME INTERIM CHAIRMAN AND CEO..
AQ
2021Ampio Pharmaceuticals Chief Executive Mike Macaluso Takes Medical Leave; Interim Replac..
MT
2021Ampio Pharmaceuticals, Inc. Announces Executive Changes
CI
2021Ampio Pharmaceuticals, Inc. Announces Executive Changes
CI
2021AMPIO : Q3 Earnings Snapshot
AQ
More news
News in other languages on AMPIO PHARMACEUTICALS, INC.
2021Le directeur général d'Ampio Pharmaceuticals, Mike Macaluso, prend un congé médical ; u..
2021HISTORIQUE DES RÉACTIONS AUX BÉNÉFIC : Ampio Pharmaceuticals Inc, 66,7% d'indicateur de su..
2021Ampio obtient l'autorisation des autorités réglementaires indiennes de lancer une étude..
2021Les actions du secteur de la santé réduisent leurs gains initiaux alors que les produit..
2021Les actions du secteur de la santé s'ajoutent aux récents sommets intrajournaliers
More news
Chart AMPIO PHARMACEUTICALS, INC.
Duration : Period :
Ampio Pharmaceuticals, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AMPIO PHARMACEUTICALS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 0,48 $
Average target price 4,00 $
Spread / Average Target 733%
EPS Revisions
Managers and Directors
Michael A. Martino Chairman & Chief Executive Officer
Holli Cherevka President & Chief Operating Officer
Daniel G. Stokely Chief Financial Officer, Secretary & Treasurer
Howard Levy Chief Medical Officer
Philip H. Coelho Lead Independent Director
Sector and Competitors
1st jan.Capi. (M$)
AMPIO PHARMACEUTICALS, INC.-15.79%109
GILEAD SCIENCES, INC.-5.56%86 013
REGENERON PHARMACEUTICALS-1.60%64 979
VERTEX PHARMACEUTICALS4.59%58 397
WUXI APPTEC CO., LTD.-5.63%51 604
BIONTECH SE-41.44%36 465